Valuation Edwards Lifesciences Corporation

Stocks

Market Closed - NYSE 16:00:02 2026-11-02 EST			5-day change	1st Jan Change
93.26 ^USD	+1.36%		+4.70%	+9.40%

11-02	Edwards Lifesciences Says TAVR Superior to Surveillance in Moderate Aortic Stenosis Trial	MT
10-21	Edwards Lifesciences Corporation Receives FDA Approval For PASCAL Precision System For Tricuspid Valve Repair And PASCAL Ace With Capture Clarity System For Degenerative Mitral TEER Procedures	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,883	46,128	46,246	43,663	49,471	53,755	-	-
Change	-	-42.97%	0.25%	-5.58%	13.3%	8.66%	-	-
Enterprise Value (EV) ¹	80,616	45,956	45,198	40,285	45,843	50,124	48,560	46,744
Change	-	-42.99%	-1.65%	-10.87%	13.8%	9.34%	-3.12%	-3.74%
P/E	54.4x	30.6x	33.2x	10.6x	46.6x	37x	28.3x	25.3x
PBR	13.9x	7.82x	6.99x	4.36x	4.79x	5.07x	4.41x	4.09x
PEG	-	12.14x	-5.79x	0x	-0.6x	1x	0.9x	2.2x
Capitalization / Revenue	15.5x	8.57x	7.7x	8.03x	8.15x	7.95x	7.23x	6.57x
EV / Revenue	15.4x	8.54x	7.53x	7.41x	7.56x	7.41x	6.53x	5.72x
EV / EBITDA	46.6x	23.7x	24.1x	24.1x	25.5x	23.5x	20.3x	17.5x
EV / EBIT	50.6x	25.6x	26.1x	26.6x	27.9x	25.4x	22x	18.8x
EV / FCF	57.3x	47.2x	47.9x	139x	34.3x	54.6x	30.2x	26.7x
FCF Yield	1.74%	2.12%	2.09%	0.72%	2.91%	1.83%	3.31%	3.75%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	2.38	2.44	2.3	6.97	1.83	2.523	3.299	3.681
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	5,232	5,382	6,005	5,440	6,068	6,761	7,431	8,177
EBITDA ¹	1,729	1,936	1,879	1,670	1,800	2,137	2,395	2,668
EBIT ¹	1,594	1,796	1,734	1,514	1,644	1,970	2,211	2,480
Net income ¹	1,503	1,522	1,402	4,175	1,074	1,458	1,882	2,019
Net Debt ¹	-267	-172.7	-1,048	-3,378	-3,628	-3,631	-5,195	-7,011
Reference price ²	129.55	74.61	76.25	74.03	85.25	93.26	93.26	93.26
Nbr of stocks (in thousands)	624,334	618,260	606,500	589,800	580,300	576,400	-	-
Announcement Date	1/26/22	1/31/23	2/6/24	2/11/25	2/10/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
EDWARDS LIFESCIENCES CORPORATION	36.47x	7.31x	23.11x	-.--%	53.03B
THERMO FISHER SCIENTIFIC, INC.	35.69x	6.08x	23.25x	0.27%	258B
DANAHER CORPORATION	36.92x	7x	21.93x	0.62%	163B
INTUITIVE SURGICAL, INC.	49.76x	12.05x	25.86x	-.--%	150B
BOSTON SCIENTIFIC CORPORATION	17.17x	3.45x	11.25x	-.--%	60.84B
SIEMENS HEALTHINEERS AG	21x	2.51x	12.66x	2.4%	53.31B
VEEVA SYSTEMS INC.	47.92x	11.82x	26.05x	-.--%	50.67B
AGILENT TECHNOLOGIES, INC.	34.07x	6.75x	22.92x	0.59%	49.3B
WATERS CORPORATION	81x	7.7x	23.37x	-.--%	45.46B
ILLUMINA, INC.	47.04x	7.69x	27.3x	-.--%	35.68B
Average	40.71x	7.24x	21.77x	0.39%	91.97B
Weighted average by Cap.	39.44x	7.40x	22.32x	0.36%